You are here
The Office of Science Policy (OSP) advises the NIH Director on science policy issues affecting the medical research community and participates in the development of new policy and program initiatives. In addition to monitoring and coordinating agency planning and evaluation activities OSP also plans and implements a comprehensive science education program. OSP is also responsible for developing and implementing NIH policies and procedures for the safe conduct of recombinant DNA and other biotechnology activities.
- Office of Biotechnology Activities (OBA)
- Office of Clinical Research and Bioethics Policy (OCBRP)
- Office of Science Management and Reporting (OSMR)
The Office of Legislative Policy and Analysis (OLPA) serves as the principal office within the Office of the Director (OD), National Institutes of Health (NIH), for providing legislative analysis, policy development, and liaison with the Congress. OLPA facilitates and enhances the relationship between NIH and the Congress; advances NIH legislative priorities; and ensures that the NIH community receives essential information, advice, and guidance regarding developments in the Congress that affect NIH.
This page last reviewed on January 26, 2016